[ad_1] NESS ZIONA, Israel, November 12, 2018 /PRNewswire/ — Israeli biotechnology company Kadimastem (TASE: KDST) announces the approval by the European Union and the Israel Innovation Authority, to receive a joint research …
Read More »
[ad_1] CHICAGO — Dapagliflozin (Farxiga/Forxiga, AstraZeneca) showed a nonsignificant trend toward a reduced rate of major adverse cardiac events (MACE) but significantly reduced hospitalization for heart failure in the DECLARE-TIMI 58 trial in …
Read More »
[ad_1] A drug developed by AstraZeneca has markedly reduced the chances of diabetic patients being hospitalized with heart failure, a condition badociated with type 2 diabetes. The findings, from a large clinical …
Read More »
[ad_1] Health The biggest clinical trial so far to badess a new clbad of diabetes pills shows that AstraZeneca’s Farxiga can prevent heart failure and cut the risk of kidney problems in …
Read More »
[ad_1] Stericycle Q3 beats EPS, misses sales expectations on The Street Stericycle (Nasdaq: SRCL) today posted third quarter of the year. The Lake Forest, Ill.-based company posted profits of $ 23.5 million, …
Read More »
[ad_1] Israeli diabetes prediction and prevention platform Sweetch, the first AI-powered therapeutics solution to help people with the disorder, announced this week it will partner with US-based integrated health care system WellSpan …
Read More »